Pediatric COVID-19 severity appears to be declining among hospitalized children as Omicron subvariants evolve.
The FDA approved 2025-2026 COVID vaccines from Pfizer (Comirnaty), Moderna (Spikevax, mNexspike), and Novavax (Nuvaxovid), the companies announced on Wednesday. But the agency removed one of the ...